Plasma Surgical
Private Company
Funding information not available
Overview
Plasma Surgical is a private medical device innovator specializing in pure-plasma energy technology for surgery. Its flagship product, the PlasmaJet Ultra+, is an all-in-one surgical instrument designed for precision tissue management with minimal thermal spread, targeting complex soft tissue procedures. The company is commercial in Europe, Australia, and New Zealand, with a primary focus on gynecological oncology and endometriosis, aiming to enable more conservative, minimally invasive surgeries and improve patient outcomes.
Technology Platform
Pure-Plasma energy technology generating a controlled, rapidly dissipating stream of ionized gas for precise surgical cutting, dissection, vaporization, coagulation, and surface sealing of soft tissue with minimal lateral thermal damage.
Opportunities
Risk Factors
Competitive Landscape
Competes in the surgical energy device market against major players like Medtronic (electrosurgery), Johnson & Johnson (Ethicon), and Olympus, who offer ultrasonic (e.g., Harmonic), advanced bipolar, and laser devices. PlasmaJet's differentiation is its pure-plasma technology, which claims superior precision and minimal thermal spread compared to these alternatives.